Palyon Medical Corp.
Investors: Nextech Venture.
Details: Develops implantable drug delivery systems. The funding brings the Series A round total to $24M. In April, the company raised $21M from Baird Venture Partners (led), Hambrecht & Quist Capital Management, Fountain Healthcare Partners, BB Biotech Ventures, Cross Atlantic Partners and Arcus Ventures.
Investors: OVP Venture Partners, ARCH Venture Partners, Alexandria Real Estate Equities, Amgen Ventures, WRF Capital
Details: Operates as an antibody discovery and development platform. This is the 10th company backed by Seattle-based Accelerator Corp. and the second Accelerator-backed startup founded from intellectual property developed at the University of Washington.
Minyanville Media Inc.
Details: Operates a financial news and information website. In a regulatory filing, the company stated that it may raise as much as $13M “depending on an investment by a specific potential strategic partner.”
Investors: Tech Coast Angels.
Details: Operates an online sports network called Loop’d for sports enthusiasts. The company has now raised more than $3.2M in funding.
Aha Mobile Inc.
Palo Alto, Calif.
Details: Develops a mobile application that provides information to automobile drivers. The company is still developing its beta version and is preparing to launch its program for the iPhone this summer.
Investors: Centennial Ventures.
Details: Makes portable music devices. The funding is a first close on an expected $10.2M round of venture funding, according to a regulatory filing. The company has now raised about $55 million from Centennial Ventures, Rho Ventures, Austin Ventures, Mission Ventures and Sevin Rosen Funds.
Investors: Blumberg Capital (led), First Round Capital, Genacast Ventures and individual investors.
Details: Tracks online ads. David Blumberg, managing partner of Blumberg Capital; Chris Fralic, partner of First Round Capital; and Gil Beyda, managing partner of Genacast Ventures have joined the board.
Anulex Technologies Inc.
Investors: Delphi Ventures, New Enterprise Associates, St. Paul Venture Capital, Affinity Capital Management, MB Venture Partners, SightLine Partners.
Details: Develops medical devices for the orthopedic market. The company had previously raised about $34M.
Control Medical Technology
Park City, Utah
Investors: Spring Bay Ventures.
Details: Develops medical devices for general biopsy.
iRhythm Technologies Inc.
Investors: Mohr Davidow Ventures, Synergy Life Science Partners, Stanford University, UNC Kenan-Flagler Private Equity Fund.
Details: Develops a cardiac monitoring device. The company had previously raised $12.7M and won a $10K business plan competition.
Orasi Medical Inc.
Investors: CentreStone Ventures, PrairieGold Venture Partners.
Details: Develops technology to diagnose and monitor neurological disorders. The company has now raised nearly $6M since late 2007.
Pathway Medical Technologies Inc.
Investors: WRF Capital and an undisclosed investor.
Details: Develops medical devices intended for the treatment of arterial diseases. WRF Capital, the venture arm of the Washington Research Foundation, invested $1.5M in the round. The funding brings the Series D round total to $42.5M. Other investors in the round include Forbion Capital Partners, Giza Venture Capital, HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners and individual investors. The company has now raised about $125M in funding since 1999.
La Jolla, Calif.
Investors: S.R. One Ltd., Versant Ventures, Aravis SA, 5AM Ventures, Apposite Capital, Merck Serono Ventures.
Details: Develops protein therapeutics to treat cancer and immune-mediated diseases. The funding brings the Series A round total to $38M. Simeon George, partner of S.R. One, has joined the board.
Cempra Pharmaceuticals Inc.
Chapel Hill, N.C.
Investors: Quaker BioVentures (led), Devon Park Bioventures, Aisling Capital, Intersouth Partners, Teachers’ Private Capital and individual investor Wistar Morris III.
Details: Develops antibiotics for difficult-to-treat and drug-resistant infections. The company previously raised about $32M. Geeta Vemuri, partner at Quaker BioVentures, has joined the board.
Elixir Pharmaceuticals Inc.
Investors: MPM Capital, ARCH Venture Partners, Oxford Bioscience Partners, Physic Ventures.
Details: Develops drugs to treat metabolic disease.
Mountain View, Calif.
Investors: Thomvest Ventures.
Details: Provides data protection software-as-a-service focused on small and medium-sized businesses. The funding brings the Series A round to $8M after having raised $6M last fall from Allegis Capital and Peninsula Ventures.